Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 13, Number 4—April 2007

Letter

VIM-2–producing Pseudomonas putida, Buenos Aires

Marisa Almuzara*, Marcela Radice*, Natalia de Gárate*, Alejandra Kossman*, Arabela Cuirolo*, Gisela Santella*, Angela Famiglietti*, Gabriel Gutkind*Comments to Author , and Varolos Vay*
Author affiliations: *Universidad de Buenos Aires, Buenos Aires, Argentina;

Main Article

Table

Antimicrobial drug susceptibility profiles of 2 blaVIM-2-carrying Pseudomonas putida isolates, Argentina

Drug MIC (μg/mL)
Isolate 1 Isolate 2
Imipenem 32 64
Meropenem 64 64
Ertapenem 128 128
Piperacillin 64 64
Piperacillin-tazobactam 32 32
Ceftazidime 128 128
Cefepime 32 32
Aztreonam 64 64
Amikacin 4 4
Gentamicin 16 16
Ciprofloxacin >64 >64
Gatifloxacin >64 >64
Levofloxacin >64 >64
Moxifloxacin >64 >64
Doxycycline 64 64
Colistin 2 2

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO